BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 22098667)

  • 1. Effect of bile duct ligation on bile acid composition in mouse serum and liver.
    Zhang Y; Hong JY; Rockwell CE; Copple BL; Jaeschke H; Klaassen CD
    Liver Int; 2012 Jan; 32(1):58-69. PubMed ID: 22098667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic preconditioning protects BSEP/ABCB11
    Fuchs CD; Paumgartner G; Wahlström A; Schwabl P; Reiberger T; Leditznig N; Stojakovic T; Rohr-Udilova N; Chiba P; Marschall HU; Trauner M
    J Hepatol; 2017 Jan; 66(1):95-101. PubMed ID: 27593105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
    Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
    Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice.
    Woolbright BL; Antoine DJ; Jenkins RE; Bajt ML; Park BK; Jaeschke H
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):524-31. PubMed ID: 24096036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury.
    Zhang Y; Csanaky IL; Cheng X; Lehman-McKeeman LD; Klaassen CD
    Toxicol Sci; 2012 Jun; 127(2):451-62. PubMed ID: 22461449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis.
    Woolbright BL; Dorko K; Antoine DJ; Clarke JI; Gholami P; Li F; Kumer SC; Schmitt TM; Forster J; Fan F; Jenkins RE; Park BK; Hagenbuch B; Olyaee M; Jaeschke H
    Toxicol Appl Pharmacol; 2015 Mar; 283(3):168-77. PubMed ID: 25636263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasis.
    Cai SY; Yu D; Soroka CJ; Wang J; Boyer JL
    J Hepatol; 2021 Mar; 74(3):550-559. PubMed ID: 33039404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis.
    Allen K; Jaeschke H; Copple BL
    Am J Pathol; 2011 Jan; 178(1):175-86. PubMed ID: 21224055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity and intracellular accumulation of bile acids in sandwich-cultured rat hepatocytes: role of glycine conjugates.
    Chatterjee S; Bijsmans IT; van Mil SW; Augustijns P; Annaert P
    Toxicol In Vitro; 2014 Mar; 28(2):218-30. PubMed ID: 24211540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Value of Cellular Accumulation of Hydrophobic Bile Acids As a Marker of Cholestatic Drug Potential.
    Burban A; Sharanek A; Humbert L; Eguether T; Guguen-Guillouzo C; Rainteau D; Guillouzo A
    Toxicol Sci; 2019 Apr; 168(2):474-485. PubMed ID: 30629237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response.
    Cai SY; Ouyang X; Chen Y; Soroka CJ; Wang J; Mennone A; Wang Y; Mehal WZ; Jain D; Boyer JL
    JCI Insight; 2017 Mar; 2(5):e90780. PubMed ID: 28289714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor.
    Zhang L; Shi J; Shen Q; Fu Y; Qi S; Wu J; Chen J; Zhang H; Mu Y; Chen G; Liu P; Liu W
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116833. PubMed ID: 37400008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17A synergistically enhances bile acid-induced inflammation during obstructive cholestasis.
    O'Brien KM; Allen KM; Rockwell CE; Towery K; Luyendyk JP; Copple BL
    Am J Pathol; 2013 Nov; 183(5):1498-1507. PubMed ID: 24012680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in expression and immunolocalization of protein associated with toxic bile salts-induced apoptosis in rat hepatocytes.
    Oh SH; Yun KJ; Nan JX; Sohn DH; Lee BH
    Arch Toxicol; 2003 Feb; 77(2):110-5. PubMed ID: 12590363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice.
    Weerachayaphorn J; Luo Y; Mennone A; Soroka CJ; Harry K; Boyer JL
    J Hepatol; 2014 Jan; 60(1):160-6. PubMed ID: 23978715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurocholate Induces Connective Tissue Growth Factor Expression in Hepatocytes Through ERK-YAP Signaling.
    Yu B; Jin GN; Ma M; Liang HF; Zhang BX; Chen XP; Ding ZY
    Cell Physiol Biochem; 2018; 50(5):1711-1725. PubMed ID: 30384360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
    Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
    Baghdasaryan A; Fuchs CD; Österreicher CH; Lemberger UJ; Halilbasic E; Påhlman I; Graffner H; Krones E; Fickert P; Wahlström A; Ståhlman M; Paumgartner G; Marschall HU; Trauner M
    J Hepatol; 2016 Mar; 64(3):674-81. PubMed ID: 26529078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
    Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
    Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.